-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 3, the Guangzhou Gilead-Richardson Joint Innovation Center was inaugurated on Guangzhou International Biological Island, and was jointly established by Guangzhou Huangpu District, Guangzhou Development Zone, Guangzhou High-tech Zone and world's top 500 enterprise Slit-Unguist Science Co., and Richardson Medical, the world's leading fungal diagnostic testing laboratory, the first third-party independent fungal laboratory in China, which will fill the gap in diagnostic testing of invasive fungi in China.
"from January 20 this year signed a contract to settle on Bio Island, to the laboratory completed and approved the license, the whole process only 112 days, fully demonstrated the speed of the region, which is also the speed of Guangzhou."
Said, said Luo Yongqing, general manager of Gilead Science china. "We will integrate international resources and establish international collaborationtos to create the world's leading fungal reference laboratory,"
.
" Professor Maxim Richardson, who runs the center's draughts, said in a video message from the event.
at present, the biosecurity problem caused by microorganisms, especially pathogenic microorganisms, is the most important and realistic biosecurity problem facing human society.
according to statistics, there are about 2.5 million patients with deep fungal infections in China every year.
in response to the global problem of fungal infection, The Guangzhou Gilead-Richardson Joint Innovation Center will integrate innovative technologies and top talents in the field of fungi at home and abroad, open the deep fungal infection industry chain from prevention and diagnosis to treatment, promote the development of innovative drugs and testing technologies related to fungal infection from research and development to clinical application, fill the gaps in domestic related technologies, develop Chinese fungal diagnosis and treatment standards, and build a world-class innovation innovation platform in China in the field.
it is understood that the center also plans to introduce the world's most advanced and most mature fungal diagnostic technology into Guangzhou, Europe's top fungal laboratory to use diagnostic reagents domestic, the establishment of the GreatEring Bay Fungal Research Institute, to promote China's invasive fungal diagnostic testing guidelines, standard-setting, to shorten the gap between China and the international fungal diagnosis level, 1 to achieve rapid and accurate diagnosis, reduce medical expenditure, benefit more patients.
in addition, with a number of domestic top three-center hospitals set up a multi-center clinical cooperation platform, will be in the field of public health, especially in the field of fungi to train more innovative and entrepreneurial talent.
with the completion of the Guangzhou Gilead-Richardson Joint Innovation Center, Guangzhou Huangpu District, Guangzhou Development Zone, Guangzhou High-tech Zone in the internationalization of biomedicine has taken a big step forward.
the region has gathered more than 600 biopharmaceutical enterprises, the biopharmaceutical industry scale reached 70 billion yuan, accounting for more than 60% of Guangzhou.
Source: Science and Technology Daily correspondent Huang Jiaqing Ou Zhibin.